Home » Abraxane in Combination With Bevacizumab Promising in Treating Breast Cancer
Abraxane in Combination With Bevacizumab Promising in Treating Breast Cancer
Abraxis BioScience, Inc., announced study results Tuesday that demonstrate a regimen of Abraxane (paclitaxel protein-bound particles for injectable suspension)
(albumin-bound) given in combination with bevacizumab (Avastin) may have potential in the treatment of triple-negative breast cancers.
Trading Markets
Trading Markets
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May